Medical Writing Services — Regulatory-Grade Scientific Documentation
Sub-headline: RABT Global delivers expert medical writing services for regulatory submissions, clinical trials, and medical communications. Our regulatory medical writing services are integrated with our RA teams for submission-ready output.
Expert medical content writing and clinical trial document writing from a regulatory-integrated medical writing team.
Medical writing services are a critical component of every pharmaceutical and medical device regulatory programme. High-quality, scientifically accurate, and regulatory-compliant documentation is not just a box-ticking exercise — it is often the difference between a successful first-round approval and a deficiency letter that delays your launch by months.
At RABT Global, our medical writing consulting services are fully integrated with our regulatory affairs teams — ensuring that every document we produce is not only scientifically accurate but strategically aligned with your regulatory submission objectives. Our regulatory medical writing services span the full spectrum of pharmaceutical and device documentation requirements, from early-phase clinical trial documents to complex post-approval regulatory dossiers.
Our team of scientific writers combines advanced qualifications in biomedical sciences, pharmacology, and regulatory affairs with hands-on experience in producing documents that meet FDA, EMA, MHRA, and ICH standards. Whether you need clinical medical writing services for an IND/CTA package, medical writing for regulatory submissions, or end-to-end medical writing support for a full CTD dossier, RABT Global delivers documentation that works.
Our Medical Writing & Communications Services
Clinical Study Reports (CSR)
ICH E3-compliant CSRs prepared from your study data and statistical analysis reports
Investigator’s Brochures (IB)
up-to-date, ICH E6-compliant IBs for clinical trial programmes
CTD Module 2 Summaries
non-clinical overviews, clinical overviews, and quality summaries for regulatory submissions
Clinical Evaluation Reports (CER)
EU MDR-compliant CERs for medical device CE marking
Clinical Trial Protocol Writing
Phase I–IV protocol preparation, amendment writing, and ICH E8-aligned design
Patient Narratives & PBRER/PSUR
pharmacovigilance medical writing including individual case narratives and periodic safety reports
Regulatory Response Writing
health authority query responses, deficiency letter responses, and supplemental submissions
Scientific Content Writing
medical content writing for publications, regulatory dossiers, and scientific communications
Standard Operating Procedures (SOPs)
GCP/GMP-compliant SOP writing for clinical and quality operations
What are Medical Writing Services in Regulatory Affairs?
Medical writing services in regulatory affairs involve the preparation of scientific and technical documents required for pharmaceutical and medical device regulatory submissions. These include clinical study reports, investigator brochures, CTD summaries, clinical evaluation reports, regulatory response documents, and other submission-critical materials. Regulatory medical writing services are provided by qualified medical writers with expertise in both scientific communication and health authority regulatory requirements.
Medical Writing Services — FAQs
A: RABT Global’s medical writing team holds advanced qualifications including MSc, MPharm, and PhD in biomedical and pharmaceutical sciences, combined with regulatory affairs training (TOPRA, RAPS). All our writers have extensive experience in pharmaceutical and/or medical device regulatory writing to ICH, FDA, and EMA standards.
A: Yes. Our regulatory medical writing services are designed specifically for regulatory submission contexts — preparing documents to the exact format, content, and quality standards required by FDA, EMA, MHRA, and other health authorities. We integrate our medical writing with our RA team to ensure complete dossier coherence.
A: Yes. Our medical writing consulting services include device-specific documentation — Clinical Evaluation Reports (CER), Post-Market Clinical Follow-Up (PMCF) plans, Summary of Safety and Clinical Performance (SSCP), EU MDR post-market surveillance reports (PMSR/PSUR), and FDA device-related technical documentation.
A: Our medical writing process includes scientific peer review by subject matter experts, regulatory compliance review against applicable guidelines (ICH, EU MDR, FDA guidance), and quality review by our quality management team. All medical writing deliverables are produced under our ISO-aligned document management system.
Submission-Ready Medical Writing — Integrated with Your Regulatory Strategy
Expert medical writing services from a regulatory-first team. Clinical trial documents, CTD modules, CERs, and regulatory responses — all to submission-ready standard.